Presenter: Brendan Munden, MSW, RSW Clinical Supervisor for ACT 1 Vancouver Coastal Health Assertive Community Treatment Team 1
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025